Infliximab vs. adalimumab in Crohn's disease: Results from 327 patients in an Australian and New Zealand observational cohort study

Alimentary Pharmacology and Therapeutics

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/2imGigc
via IFTTT